A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.
Clinical trial NCT06586216 · COMPLETED
Trial details
- NCT number
- NCT06586216
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2025-02-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.